ViBone in Cervical and Lumbar Spine Fusion

NCT03425682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2025-03-04

Study results available
· View outcomes & findings →

Summary

Assess clinical and radiographic outcomes in patients who undergo 1-3 level anterior cervical discectomy fusion (ACDF) or lumbar interbody fusion (TLIF, PLIF, ALIF, or LLIF) using ViBone.

Conditions

  • Spondylosis
  • Cervical Spondylosis
  • Spondylolisthesis
  • Herniated Nucleus Pulposus
  • Degenerative Disc Disease

Interventions

OTHER

ViBone

Viable Bone Allograft

Sponsors & Collaborators

  • Elutia Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-14
Primary Completion
2021-01-15
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03425682 on ClinicalTrials.gov